King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...

German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...

US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

The top 20 global biopharmaceutical companies saw their combined market capitalization rise 4% in the third quarter of 2025 ...

Merck & Co (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, while adjusted earnings rose ...

Germany-based biotech Tubulis today announced a second and final closing of its Series C round totaling 344 million euros ...

US pharma major AbbVie saw its shares drop 4.5% to $218.04 by close of trading on Friday, despite reporting financial results for the third quarter ended September 30, 2025, that beat expectation.

Swiss pharma major Roche (ROG: SIX) has entered a global exclusive licensing agreement with China’s Qyuns Therapeutics for ...

China’s R&D and manufacturing services provider WuXi AppTec has reached agreement for Hillhouse Investment Management to ...

Australian biotech Myrio Therapeutics has joined forces with the University of Pennsylvania’s Perelman School of Medicine and ...